New Shocking Study Shows Covid Booster Effectiveness Against Hospitalization Plunging To 55% After Only 3 Months | Not Everyone Gains Protection From Antibodies But They Do From T-Cells | Leronlimab
New Shocking Study Shows Covid Booster Effectiveness Against Hospitalization Plunging To 55% After Only 3 Months | Not Everyone Gains Protection From Antibodies But They Do From T-Cells | Leronlimab
jamescintolo.substack.com
If you have not seen the new studies referenced in the title of this article you need to because they will likely change the Covid narrative in the not so distance future. So, what studies exactly? Well, The Lancet (a peer reviewed medical journal) just released a paper showing Covid booster effectiveness plunging to 55% against hospitalization while still conferring serious side effects. Also, another study released on 4/22/22 revealed that many times antibodies were not produced after a Covid infection. Instead, more frequently, CD8+ & CD4+ T- cells were generated which are the unsung heroes protecting most people previously infected, or vaccination against severe disease/illness. Finally, a new study suggested Leronlimab to be an effective monoclonal antibody against severe Covid. ETC.
New Shocking Study Shows Covid Booster Effectiveness Against Hospitalization Plunging To 55% After Only 3 Months | Not Everyone Gains Protection From Antibodies But They Do From T-Cells | Leronlimab
New Shocking Study Shows Covid Booster…
New Shocking Study Shows Covid Booster Effectiveness Against Hospitalization Plunging To 55% After Only 3 Months | Not Everyone Gains Protection From Antibodies But They Do From T-Cells | Leronlimab
If you have not seen the new studies referenced in the title of this article you need to because they will likely change the Covid narrative in the not so distance future. So, what studies exactly? Well, The Lancet (a peer reviewed medical journal) just released a paper showing Covid booster effectiveness plunging to 55% against hospitalization while still conferring serious side effects. Also, another study released on 4/22/22 revealed that many times antibodies were not produced after a Covid infection. Instead, more frequently, CD8+ & CD4+ T- cells were generated which are the unsung heroes protecting most people previously infected, or vaccination against severe disease/illness. Finally, a new study suggested Leronlimab to be an effective monoclonal antibody against severe Covid. ETC.